Literature DB >> 27400276

Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression.

Zara A Ioannides1, Shyuan T Ngo, Robert D Henderson, Pamela A McCombe, Frederik J Steyn.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the death of motor neurones, which leads to paralysis and death in an average of 3 years following diagnosis. The cause of ALS is unknown, but there is substantial evidence that metabolic factors, including nutritional state and body weight, affect disease progression and survival. This review provides an overview of the characteristics of metabolic dysregulation in ALS focusing on mechanisms that lead to disrupted energy supply (at a whole-body and cellular level) and altered energy expenditure. We discuss how a decrease in energy supply occurs in parallel with an increase in energy demand and leads to a state of chronic energy deficit which has a negative impact on disease outcome in ALS. We conclude by presenting potential and tested strategies to compensate for, or correct this energy imbalance, and speculate on promising areas for further research.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27400276     DOI: 10.1159/000446502

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  14 in total

1.  Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis.

Authors:  Jin-Yue Li; Li-Ying Cui; Xiao-Han Sun; Dong-Chao Shen; Xun-Zhe Yang; Qing Liu; Ming-Sheng Liu
Journal:  Ann Clin Transl Neurol       Date:  2022-05-18       Impact factor: 5.430

2.  Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis.

Authors:  Maurine C Braun; Alexandra Castillo-Ruiz; Premananda Indic; Dae Young Jung; Jason K Kim; Robert H Brown; Steven J Swoap; William J Schwartz
Journal:  Exp Neurol       Date:  2018-07-18       Impact factor: 5.330

3.  Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target.

Authors:  Silvia Scaricamazza; Illari Salvatori; Giacomo Giacovazzo; Jean Philippe Loeffler; Frederique Renè; Marco Rosina; Cyril Quessada; Daisy Proietti; Constantin Heil; Simona Rossi; Stefania Battistini; Fabio Giannini; Nila Volpi; Frederik J Steyn; Shyuan T Ngo; Elisabetta Ferraro; Luca Madaro; Roberto Coccurello; Cristiana Valle; Alberto Ferri
Journal:  iScience       Date:  2020-04-21

4.  Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.

Authors:  Ikjae Lee; Mohamed Kazamel; Tarrant McPherson; Jeremy McAdam; Marcas Bamman; Amy Amara; Daniel L Smith; Peter H King
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

5.  Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?

Authors:  Patrizia Bossolasco; Raffaella Cancello; Alberto Doretti; Claudia Morelli; Vincenzo Silani; Lidia Cova
Journal:  J Neuroinflammation       Date:  2017-04-20       Impact factor: 8.322

Review 6.  Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions.

Authors:  Shyuan T Ngo; Jia D Mi; Robert D Henderson; Pamela A McCombe; Frederik J Steyn
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-07-25

7.  Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches.

Authors:  Ping Zeng; Xinghao Yu; Haibo Xu
Journal:  Front Neurol       Date:  2019-05-24       Impact factor: 4.003

Review 8.  CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?

Authors:  Tesfaye Wolde Tefera; Frederik J Steyn; Shyuan T Ngo; Karin Borges
Journal:  Cell Biosci       Date:  2021-01-11       Impact factor: 7.133

9.  Amyotrophic Lateral Sclerosis and Occupational Exposures: A Systematic Literature Review and Meta-Analyses.

Authors:  Lars-Gunnar Gunnarsson; Lennart Bodin
Journal:  Int J Environ Res Public Health       Date:  2018-10-26       Impact factor: 3.390

10.  Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis.

Authors:  Jiayu Fu; Ji He; Wei Zhao; Chuan Ren; Ping Liu; Lu Chen; Dan Li; Lu Tang; Lequn Zhou; Yixuan Zhang; Xinran Ma; Gaoqi Zhang; Nan Li; Dongsheng Fan
Journal:  J Neurol       Date:  2021-07-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.